Skip to content
Home
Careers with Us
Products
Member Center
Shop
Cart
Contact Us
Home
Careers with Us
Products
Member Center
Shop
Cart
Contact Us
฿
0.00
0
Cart
สมัครสมาชิก
เข้าสู่ระบบ
News
Lee’s Pharmaceutical participated in the 86th PharmChina
May 15, 2023
The Group’s in-house developed product Socazolimab Injection was successfully launched in China
January 16, 2024
Lee’s Pharm was proudly awarded the “Caring Company Logo” for three consecutive years
February 17, 2023
The 3rd Sino-Europe Brain and Body Academic Conference 2026 Successfully Concludes: Featured Session on “Frontiers and Clinical Practice in Psycho-Cardiology” and Media Briefing for the Sino-Europe Innovative Medical Education Program
October 20, 2026
Lee’s Pharm participated in BIOHK2024, focusing on rare disease drug innovation
September 16, 2024
Unicycive announces Exclusive License and Development Agreement with Lee’s Pharmaceutical Holdings Limited for Renazorb in China and certain other Asian markets
July 18, 2022
Lee’s Pharm was honoured with “2021 Top 100 Chinese Chemical Pharmaceutical Companies” Award
July 16, 2022
Lee’s Pharm was proudly awarded again the “Caring Company Logo”
July 25, 2022
Dr. Li Xiaoyi, the founder of Lee’s Pharm was recognized as “High-Level Talent in Guangzhou Nansha New Zone (Free Trade Zone)”
December 23, 2021
Donation of ERT-PCR Technology for New Coronavirus Detection Press Conference
March 3, 2020
A Recap of 2025 The 2nd Sino-European Brain-Heart Alliance Academic Conference in Shanghai
July 11, 2025
The Group’s in-licensed product Adasuve® (Loxapine for Inhalation) obtained Drug Registration Certificate
December 4, 2023
Previous
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Next
English
Thai
English
✕